Translational Development Acquisition Corp. (NASDAQ:TDACU) Short Interest Update

Translational Development Acquisition Corp. (NASDAQ:TDACU) saw a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 3 shares, a growth of 200.0% from the July 15th total of 1 shares. Based on an average daily trading volume, of 87 shares, the days-to-cover ratio is presently 0.0 days.

Translational Development Acquisition Price Performance

TDACU stock remained flat at $12.57 during midday trading on Friday. Translational Development Acquisition has a 12 month low of $10.71 and a 12 month high of $17.29. The company has a fifty day moving average price of $12.04 and a two-hundred day moving average price of $11.20.

About Translational Development Acquisition

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.